Catalyst Wire Dossier Catalyst Wire Dossier

NMX8 Automated Insulin Delivery System

· Medtronic MiniMed, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NMX8 Automated Insulin Delivery System, covering 2025-11-13 to 2025-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS) [NA]

See pricing